• 1
    McLellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'Brien C. P. The effects of psychosocial services in substance abuse treatment. JAMA 1993; 269: 19531959.
  • 2
    Centers for Disease Control and Prevention (CDC). Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. Morb Mortal Wkly Rep 2010; 59: 705709.
  • 3
    Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363: 19811985.
  • 4
    Substance Abuse and Mental Health Services Administration (SAMHSA). Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008. Washington, DC: Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA); 2010 15 July.
  • 5
    Boyd S., Fang L. J., Medoff D., Dixon L., Gorelick D. Use of a ‘microecologic technique’ to study crime incidents around methadone maintenance treatment centres. Addiction 2012; 107: 16321638.
  • 6
    Rich J. D., Boutwell A. E., Shield D. C., Key R. G., McKenzie M., Clarke J. G. et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health 2005; 82: 411419.
  • 7
    Rich J. D., McKenzie M., Shield D. C., Wolf F. A., Key R. G., Poshkus M. et al. Linkage with methadone treatment upon release from incarceration: a promising opportunity. J Addict Dis 2005; 24: 4959.
  • 8
    Nunn A., Zaller N., Dickman S., Trimbur C., Nijhawan A., Rich J. D. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 2009; 105: 8388.